Study of SIM0609 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational new drug, SIM0609, for people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see early signs that it might help slow or shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have given your consent to join the trial.
- You have a solid tumor that is locally advanced or has spread, and you have already tried the usual treatments without success.
- You have at least one tumor that can be measured or seen on scans.
- You are in generally good health (able to take care of yourself, ECOG 0 or 1) and expected to live 3 months or more.
- You are willing to provide a stored tumor sample or have a new biopsy taken.
- You do not have serious health problems like uncontrolled infections, active other cancers, severe heart or lung disease, or HIV/hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage trial testing a new drug called SIM0613 for advanced cancers that have spread or grown despite other treatments. The drug is designed to target cancer cells using a special delivery system.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a new drug (SIM0686) in people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and how it affects tumors that have a specific protein called FGFR2b on their surface.
This trial tests a combination of two experimental drugs, Simmitinib and SG001, in people with advanced solid tumors that have stopped responding to standard treatments. It aims to find out if this combination is safe and effective.
This trial tests a new drug, SYS6043, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can help shrink or control the tumor.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
Hear when a new Advanced Solid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.